
MaxCyte, a global cell-based therapies and life sciences company, and Myeloid Therapeutics, a company harnessing and reprogramming myeloid cells to …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

